Dupixent Lawsuit in Idaho - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Idaho's rapidly growing population — fueled by migration from California, Washington, and Oregon — has expanded the state's Dupixent prescribing base to an estimated 14,000 patients since 2017. The Boise metropolitan area accounts for the majority of the state's dermatology and allergy prescriptions, with Saint Alphonsus and St. Luke's health systems providing primary specialty care. Idaho lacks an NCI-designated cancer center, and Dupixent patients developing CTCL symptoms are typically referred to the Huntsman Cancer Institute at the University of Utah in Salt Lake City for specialized cutaneous lymphoma evaluation. Idaho's Product Liability Reform Act provides a specific statutory framework for pharmaceutical claims, including a 2-year limitations period and potential statute of repose considerations. The District of Idaho in Boise has limited pharmaceutical litigation experience, and most cases will benefit from federal MDL coordination.

Written By

People's Justice Legal Research Team

Statute of Limitations

Idaho: 2 years for product liability (Idaho Code § 6-1403). Discovery rule applies — the statute begins when the plaintiff discovers or should have discovered the injury and its cause. Idaho has a specific product liability statute of limitations.

2 years from discovery of injury

Filing Venue

Where to File in Idaho

Idaho has a single federal judicial district — the District of Idaho, with courthouses in Boise and Pocatello. Idaho follows a modified comparative fault system (50 percent bar). Idaho's Product Liability Reform Act (Idaho Code § 6-1401 et seq.) governs pharmaceutical claims and includes a statute of repose that may limit certain claims. Idaho does not cap compensatory damages but has modified punitive damage standards.

Idaho Data

Exposure in Idaho

Source: IQVIA prescription data estimates

Source: National Cancer Institute

Source: Idaho Code § 6-1401 et seq.

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview